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Jan Cameron1*, Peter G Rendell2, Chantal F Ski1, Christina E Kure1, Skye N McLennan2, Nathan S Rose2,3,
David L Prior4 and David R Thompson1Abstract
Background: Cognitive impairment is seen in up to three quarters of heart failure (HF) patients and has a significant
negative impact on patients’ health outcomes. Prospective memory, which is defined as memory to carry out future
intentions, is important for functional independence in older adults and involves application of multiple cognitive
processes that are often impaired in HF patients. The objective of this study is to examine the effects of prospective
memory training on patients’ engagement in HF self-care and health outcomes, carer strain and quality of life.
Methods/design: The proposed study is a randomised, controlled trial in which 200 patients diagnosed with HF, and
their carers will be recruited from 3 major hospitals across Melbourne. Eligible patients with HF will be randomised to
receive either: 1) The Virtual Week Training Program - a computerised prospective memory (PM) training program
(intervention) or 2) non-adaptive computer-based word puzzles (active control). HF patients’ baseline cognitive
function will be compared to a healthy control group (n = 60) living independently in the community. Patients will
undergo a comprehensive assessment of PM, neuropsychological functioning, self-care, physical, and emotional
functioning. Assessments will take place at baseline, 4 weeks and 12 months following intervention. Carers will
complete measures assessing quality of life, strain, perceived control in the management of the patients’ HF
symptoms, and ratings of the patients’ level of engagement in HF self-care behaviours.
Discussion: If the Virtual Week Training Program is effective in improving: 1) prospective memory; 2) self-care
behaviours, and 3) wellbeing in HF patients, this study will enhance our understanding of impaired cognitive
processes in HF and potentially is a mechanism to reduce healthcare costs.
Trial registration: Australian New Zealand Clinical Trials Registry #366376; 27 May 2014. https://
www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=366376&isClinicalTrial=False.
Keywords: Chronic heart failure, Self-care, Cognitive function, Prospective memory, Cognitive training, Randomised
controlled trialBackground
Heart failure (HF) is a chronic syndrome with multiple
symptoms that impose a significant burden on the indi-
vidual and healthcare system [1]. The prevalence of HF
is estimated at 23 million individuals worldwide and des-
pite advances in management there remains substantial* Correspondence: jan.cameron@acu.edu.au
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unless otherwise stated.risk for high morbidity and mortality [2]. Cognitive
impairment, which has been found to occur in up to
75% of HF patients [3], is a comorbidity that is gaining
increased recognition as adding to HF morbidity and
mortality [4,5].
There is compelling evidence demonstrating that HF
patients are more vulnerable to changes in brain
processes (memory, thinking, and thoughtful decisions)
than similar matched individuals without HF [6].
Furthermore, almost three quarters of HF patients have
evidence of cognitive impairments, especially memory,al. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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applied [3]. The impact of cognitive impairment in this
vulnerable group of patients is significant as it also con-
tributes to worse health outcomes, poor engagement in
self-care and increased mortality [5,7,8].
Optimal self-care is considered an important non-
pharmacological aspect of HF management that stabi-
lises symptoms and improves health outcomes [7]. Key
self-care behaviours include adhering to prescribed HF
therapies including medications, dietary sodium and
fluid restrictions, and exercise [9]. As well as adhering to
these HF therapies, patients are taught to recognise and
manage changes in symptoms, and seek health advice
when such changes occur [9].
The significant research attention addressing methods
to optimise HF self-care has also drawn attention to a
host of barriers that have the potential to impede
achievement of this outcome [10,11]. In recognising
these barriers, it may not be feasible for all patients to
develop adequate self-care skills [12].
Cognitive impairment is a key barrier to HF patients’
self-care as it has a negative impact on patient’s ability
to engage in effective self-care behaviours, including ini-
tiating an appropriate and timely response to changes in
HF symptoms [5,13]. The patient’s cognitive ability to
respond to vital cues and initiate appropriate actions is
not only critical in predicting engagement in self-care, it
is frequently overlooked, with poor engagement in HF
self-care often considered to reflect poor motivation
and/or compliance [5].
Particularly relevant to cognitive ability is prospective
memory (PM), currently a topic of intense interest in
ageing and neuropsychology [14,15], although as yet
given limited attention from the standpoint of HF.
Described as remembering to carry out future intentions
[16], PM includes many of the cognitive functions
necessary in forming and initiating HF self-care deci-
sions. One example specific to HF patients is that they:
i) form the intention to weigh themselves daily, ii) hold
on to this intention and conduct this behaviour each
morning, and iii) initiate the appropriate action (reduce
daily intake of sodium and fluids) in the event of a > 2-kg
weight change. Thus, PM is not so much one specific
cognitive process, but a set of cognitive processes
involved in forming, retaining, initiating and executing
an intention [17]. Successfully performing PM tasks
requires intact functioning of multiple cognitive
domains that are often impaired in HF patients [8].
These domains primarily include: attention; working
memory; retrospective memory; and executive func-
tioning [18].
The three leading theories as to why HF patients are
vulnerable to cognitive changes are: i) chronic or inter-
mittent hypoperfusion leading to cerebral ischaemia[19]; ii) microemboli causing cerebral infarction [20];
and iii) hypoxia arising from sleep apnoea [21,22]. How-
ever, in a recent review on cognitive impairment and
cardiovascular disease [23] it was acknowledged that
normal brain function requires seven interlinking physio-
logical aspects to be intact: heart; lungs; elastic vessels;
baroreflex; cerebrovascular arteries; small cerebral vessels;
and cerebrospinal venous system. Conditions affecting
these cardiovascular organs are often mutually interre-
lated, such that when one is anatomically or functionally
altered it can lead to impaired cerebrovascular perfusion
and increased risk of neurocognitive impairment. In func-
tional neuroimaging studies of HF patients the most
frequently damaged areas are the cortical white matter,
particularly in the frontal lobes, and subcortical grey mat-
ter nuclei, particularly the thalamus, basal ganglia and
brainstem [24-27]. The neural substrates in these regions
of the brain are responsible for cognitive control opera-
tions and executive control. However, the temporal lobes
of the brain may also be disrupted [26]. The temporal
lobes play a key role in retrospective memory, which is
critical for PM. Based on current evidence, it is likely that
HF patients will have significant deficits in PM that are
likely to impact on their everyday functioning.
Studies have demonstrated that PM is critical for
maintaining functional independence in older adults
[28] and PM tasks are sensitive to abnormal ageing
[29]. The PM literature distinguishes between event-
based tasks (for example, taking extra diuretic if weight
changes by > 2 kg) and time-based tasks (for example,
weighing at set times). One of the most valid assess-
ment tools for measuring PM is Virtual Week; a
computer program designed to simulate real world
activities to test PM [30]. In preliminary analysis using
Virtual Week to assess PM, we found that, compared
with aged-matched healthy controls, HF patients had
significant deficits across all types of PM tasks, even on
those that minimised the demands for remembering
the content of the task [31]. Because of the potential
impact on health outcomes, PM represents a promising
domain for cognitive training [32]. While much of the
PM research has focused on ageing [28,29], and even
though it is established that cognitive ability is often
limited in HF patients, research to date is yet to investi-
gate PM among this clinical cohort. This study is the
first of its kind to do so and, in addition, to identify the
potential of cognitive training to promote HF self-care.
Further, we aim to examine whether carer burden
(strain, perceived control and quality of life) changes in
line with changes in PM of the HF patient.
In the area of cognitive training two main approaches
have typically been investigated: 1) strategy-based training,
which aims to compensate for limitations in underlying
cognitive processes, and 2) process-based training, which
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impaired. These training studies have improved perform-
ance on the specific tasks used in training (near transfer)
but have resulted in limited evidence for training gains
to transfer to activities that are not closely related to
the training task (far transfer) [33]. Furthermore, recent
reviews have argued that cognitive training programs have
typically implemented tasks that bear little resem-
blance to everyday life. For example, a working mem-
ory task such as learning a list of words may have
little resemblance to adhering to HF self-care behav-
iours such as daily weighing and taking prescribed
medications. Researchers have advocated the need for
more ecologically valid training programs that target
abilities such as PM [32], which is critical for maintaining
functional independence [28]. Despite the importance of
PM in daily life, there have been only a few small-scale
training studies that have targeted PM [33]. The Virtual
Week Training Program is a computerised program
designed to simulate real world activities to test and
improve PM [30]. The Virtual Week Training Program is a
computerised extension of the standard Virtual Week pro-
gram for assessing PM [30] that has a board game format
with each circuit of the board simulating a day. Embedded
within the game are hypothetical PM tasks that closely
represent PM tasks in daily life, such as taking medi-
cation with meals and attending appointments at spe-
cific times (for example, 5 pm).
Preliminary findings using a 4-week version of the
Virtual Week Training Program with healthy older
adults had promising effects for both laboratory-based
PM skills practiced (near transfer) and pragmatic PM
tasks performed in everyday life (far transfer) [33].
Fifty healthy older adults participated in either the
Virtual Week Training Program, an active control
(involving music training) or a passive control. After
the training, participants in the Virtual Week training
group showed greater improvement in a real-life PM
task, the call-back task, compared to both no-contact
and active control groups, suggesting there was some
transfer to performing PM tasks in the real world.
Furthermore, participants in the Virtual Week training
group showed a greater pre- to post-test improvement
in Timed Instrumental Activities of Daily Living
(TIADL) after PM training compared to both control
groups, indicating far transfer [33]. We aim to extend
these preliminary findings by examining the efficacy of
a 6-week PM training program using the Virtual Week
Training Program among HF patients. The impact of
Virtual Week training will also be examined with
regard to carer strain and quality of life. Furthermore,
our comprehensive assessments of cognitive function-
ing will enable us to examine near to far training
benefits in everyday functioning.Rationale for study
Although cognitive impairment among HF patients has
received considerable attention, this will be the first
study to specifically examine PM among this clinical
group. This study will add evidence for the impact of
cognitive impairment on HF patients and their carers by
examining how PM relates to patient engagement in HF
self-care and health outcomes. This study will also
provide evidence for the feasibility of a novel computer-
based memory training program (the Virtual Week
Training Program) and will test whether this improves
functional outcomes among HF patients.
Study aims and objectives
We will conduct a randomised controlled trial to:
1) compare and confirm cognitive deficits, including
PM deficits, of HF patients relative to healthy
matched control group;
2) examine if PM is a significant predictor of HF
self-care;
3) test the feasibility of implementing the innovative
restorative memory training;
4) examine if PM training, using the Virtual Week
Training Program, improves self-care and functional
outcomes among HF patients (near to far transfer
effects) and reduces hospital readmissions;
5) examine if PM training of HF patients changes
their careers’ burden (strain, perceived control and
contribution to patient HF self-care) and enhances
their quality of life.
Hypotheses
We hypothesise that the cognitive training will result in
improved functioning, better health outcomes and
reduced healthcare costs in this patient group. In
addition, we predict that the improved functioning of
the HF patients will reduce levels of carer burden
(strain, perceived control, contribution to patient HF
self-care) and improve their quality of life.
Methods/design
Study design
This will be a randomised controlled trial where 200
patients with HF will be randomised to receive either:
1) the Virtual Week Training Program, a computerised
adaptively difficult PM training program, or 2) non-
adaptive computer-based word puzzles. Sixty healthy
control participants, with no HF diagnosis, will also be
assessed to compare differences in baseline measures of
cognitive and psychosocial functioning. There are 4
phases to the study: 1) baseline testing; 2) 6 weeks of
cognitive training; 3) Assessment One, 2 to 4 weeks post
cognitive training; and 4) Assessment Two, 12 months
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views during each of the assessments (baseline testing,
Assessment One and Assessment Two). These will be: a)
nursing assessment including physical functioning, and
self-care; and b) PM and neurocognitive assessment, and
TIADL.
Setting
Participants will be recruited from three major metro-
politan hospitals in Melbourne, Australia.
Participant inclusion criteria
A total of 200 HF patients aged 18 years or older will be
recruited. Inclusion criteria will be: diagnosis of HF with
reduced ejection fraction (ejection fraction < 45% in the
previous 2 years) as confirmed by a cardiologist and con-
sistent with Australian guidelines [34]; attendance at a
specialist HF clinic or rehabilitation program, and/or a
disease management program with nursing follow-up
and able to participate in the study (that is adequate
vision, hearing and English comprehension). Carers will
be identified by HF patients as someone who is familiar
with and contributes to the management of their heart
condition (for example, a partner, family member, friend
or next of kin). Patients who cannot identify a carer will
still be eligible to participate in the study. All HF
patients enrolled in the study will continue to receive
usual care which can be from any combination of nurse-
led chronic disease management programs, specialised
HF outpatient clinics, or outpatient rehabilitation programs.
A key aspect of usual care is patient education and support
from a multidisciplinary team that is directed at promoting
self-care maintenance and monitoring behaviours. Healthy
control participants will be living independently in the
community without a medical diagnosis of HF and have
adequate performance on the Addenbrooke’s Cognitive
Examination Revised (ACE-R) [35].
Participant exclusion criteria
Patients will be excluded if they: do not have access to a
PC computer; do not have basic computer skills or do
not have the physical ability to use a computer keyboard;
reside in a long-term high-care facility (nursing home);
have a documented history of moderate-to-severe cogni-
tive impairment or dementia, a cerebrovascular accident,
acute myocardial infarction or have undergone cardiac
surgery in the previous 3 months; or have a terminal
diagnosis. Carers will be excluded if they have a docu-
mented history of moderate-to-severe cognitive impair-
ment or dementia or have a terminal diagnosis. Healthy
control participants will be excluded if they: reside in a
long-term high-care facility (nursing home); have
moderate-to-severe cognitive impairment or dementia;
or have experienced a cardiac event within the past6 months (cerebrovascular accident, acute myocardial
infarction or cardiac surgery).
Recruitment
Participants will be recruited over a 24-month period, or
until the required sample size is achieved. A HF nurse
will initially assess patients’ eligibility to participate in
the study: those who meet the inclusion criteria will be
referred to the study research assistant who will
approach potential participants at their outpatient
appointment, explain the study (both verbal and written
information), and obtain their consent. They will be
asked to identify if they have an informal carer or next-
of-kin who would be willing and able to complete some
questionnaires for the study. A research assistant will
contact the carer, explain the study and their involve-
ment, obtain consent and collect baseline questionnaires.
Healthy control participants will be sourced from the
community by advertisements in local newspapers and
word-of-mouth. Research assistants will screen control
participants for study eligibility, explain the study and
obtain their consent to undergo the neurocognitive
testing. Healthy control participants will be matched to
HF patients according to age, premorbid intelligence
and gender.
Baseline and follow-up measures to be collected from all
HF patient participants
A comprehensive baseline assessment of HF patients will
be conducted prior to randomisation and the first inter-
vention session. The baseline assessment will include
socio-demographic, psychosocial, cognitive and clinical
profiling using a combination of self-report and review
of patient records. Table 1 displays baseline, 4-week and
12-month assessments. The following measures will be
administered during the assessment:
I. Patient clinical and socio-demographics: age, gender,
education level, social support, employment history.
Patient clinical history, blood pathology (B-type
natriuretic peptide (BNP), urea, electrolytes, full
blood count), echocardiographic assessment of left
ventricular systolic and diastolic function and
assessment of valvular function, HF aetiology and
treatments (medications, devices, surgery), physical
examination (heart rate, blood pressure, respiratory
rate, weight).
II. Heart Failure Screening Tool (Heart-FaST) [36]:
assesses three functional domains salient to patient
engagement in self-care: physical, cognitive and
emotional functioning. Higher scores on each
barrier scale indicate worse functioning.
Preliminary analyses support the construct validity
of the Heart-FaST as a screening tool for physical,
Table 1 Assessment measures at baseline and post-intervention evaluations
Measures Baseline
Assessment Oneb Assessment Twoc
Physical functioning
Physical examination (BP/HR/RR/weight/NYHA class, BNP) X X X
Echocardiogram X X
‘Up and Go’ test X X X
Timed Instrumental Activities of Daily Living (TIADL) X X X
Unplanned readmission/survival X X
Self-care
Heart-FaST X X
Patient engagement in self-care: (SCHFI and four consulting items from the EHFScBS) X X X
Nurses and carer assessment of patient engagement in self-care X X X
Review of patient symptom monitoring diary and how they perform self-care
maintenance behaviours
X X
Control Attitudes Scale - Revised (CAS-R) X X X
Psychosocial functioning
Quality of life (SF-12)a X X X
Dyadic HF care typology X
Hospital Anxiety and Depression Scale (HADS)a X X X
Cognitive functioning for HF patients
Cognitive screen (MoCA)a X X X
Assessment of PM (MIST, brief version of Virtual Week and naturalistic task)a X X X
Working memory, executive functioning, verbal memory (CogState, N-Back, Trail Making Test)a X X X
Premorbid intelligence (NART)a X
Caregiver
Health screening questionnaire X
Caregiver (or next of kin) Contribution to Self-Care (CC-SCHFI) X X X
Control Attitudes Scale - Revised (CAS-R) X X X
Dyadic HF care typology X
Quality of life (SF-12)a X X X
Modified Caregiver Strain Index (MCSI) X X X
Proxy - IADL X X X
Key: BNP, brain natriuretic peptide; BP, blood pressure; CC-SCHFI, Caregiver Contribution Self-Care Heart Failure Index; EHFScBS, European Heart Failure Self-care
Behaviour Scale; Heart-FaST, Heart Failure Self-care Screening Tool; HF, heart failure; HR, heart rate; IADL, Instrumental Activities of Daily Living; MIST, Memory for
Intentions Screening Test; MoCA, Montreal Cognitive Assessment; NYHA class, NART; National Adult Reading TestNew York Heart Association Classification; PM,
prospective memory; RR, respiratory rate; SCHFI, Self-Care Heart Failure Index; SF-12, Short-Form 12-item health survey.
aMeasures will also be collected from healthy non-HF controls at baseline; b2 to 4 weeks post cognitive training; c12 months post cognitive training.
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engagement in HF self-care. Heart-FaST, therefore,
has the potential to assist clinicians in tailoring
educational and surveillance disease management
strategies to individual need [37].
III.Self-Care Heart-Failure Index (SCHFI) [38]: assesses
HF self-care behaviours and skills comprising 15
items rated on a 4-point scale to measure the
process of self-care. There are three sub-scales:
maintenance, management and confidence.
Responses from each of the 3 self-care scales aretransformed to a 100 point scale; higher scores
reflect superior self-care. Self-care management
scores are only computed for those patients
reporting HF symptoms of ankle swelling or trouble
breathing in the previous three months. Scaled
scores > 70 are considered adequate self-care [38].
IV.European Heart Failure Self-care Behaviour Scale
(EHFScBS) [39,40]: 4 items from this scale will
assess consulting behaviours in response to
increased dyspnoea, feet swelling, weight gain and
fatigue. Scores on the consulting subscale range
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likelihood of contacting providers for guidance when
a change in signs or symptoms suggests worsening
HF.
V. The Control Attitudes Scale - Revised (CAS-R) [41]:
assesses cardiac patients’ subjective perceived control
in relation to managing their heart condition. Each
of the 8 items is measured on a 5-point Likert scale
ranging from 1 (strongly disagree) to 5 (strongly
agree). Internal consistency in the HF population
was Cronbach’s α = 0.76, and it showed good construct
validity [41]. This scale will be administered to the HF
patients, and will be adapted for administration to the
caregivers. For example, one item on the CAS-R states:
‘If I do all the right things, I can successfully manage
my heart condition’, and will be adapted for caregivers
to state: ‘If I do all the right things, I can successfully
manage the patient’s heart condition’. Similar amend-
ments have been made in other studies investigating
the perceived control of caregivers of patients with
cardiac disorders [42,43].
VI. Short-Form 12-item health survey (SF-12) [44]:
assesses quality of life. The health survey consists of
12 items on a Likert response: 1) physical
functioning, 2) physical role, 3) bodily pain, 4)
general health, 5) vitality, 6) social functioning, 7)
emotional role, and 8) mental health. Summary scale
scores can be transformed to a scale of 0 to 10, with
higher scores representing better health [44].
VII.The ‘Up and Go’ test [45]: assesses functional
mobility; stand from sitting, walk at usual speed for
3 meters, turn and return to sitting. To allow for
test effect, an average of two timed trials will be
recorded. The test is a measure of balance, walking
ability and risk of falling in older populations and
has been shown to be consistently reliable in test-
retest analysis in patients with chronic conditions,
including HF [45].
VIII.Dyadic HF care typology [46,47]: describes the
caregiving relationship between the HF patient and
nominated carer. Both the HF participant and their
carer will, independently, identify how their
relationship functions in terms of managing HF
symptoms. Care relationship types have been
operationalised into: 1) caregiver responsible for the
majority of the care of the HF patient, 2) HF patient
responsible for the majority of their own care, 3)
caregiver and the HF patient equally responsible for
all aspects of the care, or 4) caregiver and the HF
patient responsible for different aspects of the care.
IX.Hospital Anxiety and Depression Scale (HADS) [48]:
assesses anxiety and depression. Seven of the 14
items relate to anxiety and 7 relate to depression.
Responses are provided on a Likert scale, and scoreson each scale are interpreted in ranges: normal (0 to
7), mild (8 to 10), moderate (11 to 14), and severe
(15 to 21). The 2 subscales have a mean correlation
of 0.56, the mean Cronbach’s α is 0.83 for anxiety
and 0.82 for depression [49].
X. Montreal Cognitive Assessment (MoCA) [50]:
screens for mild cognitive impairment in the
domains of: visual-spatial skills; executive functions;
language; attention; concentration; working memory;
memory recall; and orientation. Low educational
attainment is corrected by adding 1 point to the
participant’s final score for ≤ 12 years of formal
education. The highest possible score is 30 and a
score 26 and above indicates normal cognitive
function [50].
In a second interview, HF patients will undergo compre-
hensive PM and neurocognitive assessment, and TIADL,
which will take 90 to 120 minutes to complete. The sec-
ond interview will include the following:
I. Global cognitive screen. The Addenbrooke’s
Cognitive Examination Revised (ACE-R), a sensitive
cognitive screening test of global cognitive
functioning [35], measures 5 cognitive domains;
attention/orientation, memory, verbal fluency,
language and visuospatial abilities. Lower scores
suggest poor cognitive performance. ACE-R is
sensitive to early stages of dementia [51] and will
be used as a participant screen. Adequate
performance on the ACE-R is required for the
participant’s data to be included in the final data
sample.
II. Prospective memory (PM). There will be a rigorous
assessment of PM.
a. The Memory for Intentions Screening Test (MIST)
[52] is a standardised measure of PM developed for
use in clinical settings. Throughout the test,
participants will be required to remember and
perform 4 time-based (for example; ‘in exactly
15 minutes please tell me it is time to take a break’)
and 4 event-based tasks (for example: ‘when I hand
you a red pen, please sign your name on the
paper’). A series of word search puzzles will be
provided as a distractor task to prevent overt
rehearsal of the prescribed intentions. The
researcher will monitor whether the participant
remembers to perform the PM tasks correctly.
Errors and scoring will be assessed in
accordance with the MIST professional manual,
which allows for an assessment of eight
differing aspects of PM functioning. The MIST
takes 30 minutes to administer. Total scores
range from 0 to 48 with higher scores indicating
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sensitive to various neurological disorders, such
as mild cognitive impairment [53] and has good
reliability and validity [54].
b. The brief Virtual Week assessment, which
involves 2 ‘virtual’ days of the computerised
board game, will assess event-based and time-
based PM tasks. Based on our previous study with
HF patients [55], the brief version of Virtual
Week will take 30 to 45 minutes to complete.
c. The Naturalistic PM task assesses 2 types of time-
based PM tasks: 1) an appointment task at a set
time of day and 2) one requiring monitoring a
short interval of time. The latter is typical of many
laboratory-based PM tasks. Participants will be
asked to ring a prescribed number at 2 set times
over 3 consecutive days. With each scheduled
phone call, a recorded message will ask participants
to call back after an interval of 5, 10 or 20 minutes.
III.Timed Instrumental Activities of Daily Living
(TIADL). Participants’ level of independence in daily
activities will be assessed using a modified version of
the TIADL [56]. Participants are required to
complete nine activities that are relevant to tasks
they would perform at home. The original five tasks
are functional measures basic to independent living
such as telephone communications, financial
abilities, nutrition, shopping and medication use.
Four additional tasks that are more relevant in the
current technological communication environment
and specifically related to HF self-care have been
adapted for this study: 1) checking and sorting the
sodium content of 3 food packages from the lowest
to the highest amount of sodium; 2) extracting
health information from a computer screen
simulating a webpage to estimate a target heart rate
for exercise; 3) extracting data from a webpage to
look up a specified train timetable, and 4) finding a
matching pair of black socks in a laundry basket full
of mixed single socks. Participants are scored on the
length of time to complete each of the nine activities,
and if any, the type of error in performing the activity.
Shorter completion times indicate better
performance. The rapid and efficient completion of
these tasks is advantageous in daily life and the time
taken to complete the tasks is an objective indication
of functional independence [56]. This assessment will
be a key strength to the study, providing an objective
and sensitive behavioural measure to evaluate the
effectiveness of the cognitive training intervention on
everyday functional independence.
IV.Working memory and executive functioning. A
battery of tests from the CogState program will be
used (www.cogstate.com) [57,58]: i) The One BackTask assesses working memory. Participants are
presented with a succession of playing cards on a
screen and must decide if the card displayed is the
same as the one presented immediately before; ii) The
Two Back Task is presented in the same way as the
One Back Task: however, participants are required to
decide if the card displayed on screen is the same as a
card presented two cards previously. Responses that
are more accurate reflect better working memory, on
both tasks; iii) The Detection Task measures
psychomotor functioning and speed of processing.
Participants must respond as quickly as possible to a
card flipping over on screen, by pressing a button on
the keyboard. Reaction time is measured and lower
scores indicate better performance; iv) The
Identification Task measures visual attention.
Participants must decide whether a playing card
presented on screen is red, by pressing the ‘Yes’ or
‘No’ button. Reaction time is measured and lower
scores indicate better performance; v) The One Card
Learning Task measures visual learning and memory.
Participants are presented with a succession of playing
card on screen, and must decide if the card currently
displayed has been displayed previously. Accuracy of
performance is measured, with higher scores
indicating better performance. In addition to the
computer battery of tests that take only 8 minutes to
complete, there will be a pen and paper task, the Trail
Making Test (TMT) [59], which assesses planning
ability. It consists of two parts: Part A and B. In Part
A, participants are required to draw lines to connect
circles that are numbered consecutively; in Part B,
participants connect circles that are numbered or
lettered, alternating between the numeric and
alphabetic sequences. This test takes approximately
5 minutes to complete, and the participant’s score is
the total time taken to complete the task. Lower
scores on the TMT indicate higher levels of planning
ability.
V. Verbal memory. In the Hopkins Verbal Learning
Test-Revised [60,61], participants must listen to a list
of 12 words read out by the experimenter, and then
verbally recall as many words as possible from that
list. This same procedure is repeated two more
times. The participant is then asked, after a 20- to
25-minute interval, to verbally recall the same list of
words. Following this final trial, the researcher reads
out a list of 24 words and the participant is asked to
identify the words that were presented in the original
list of 12 words. This verbal memory test assesses
episodic memory and the delayed recall test is
particularly sensitive to ageing and abnormal ageing.
The test has been successfully used in clinical and
healthy populations of older adults [62].
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Test (NART) [63] is a word-recognition test of
vocabulary knowledge that requires participants to
read aloud 50 English words of increasing difficulty
that do not follow normal phonetic rules: for example,
‘chord’. This test takes about 5 minutes to complete
and responses are audio-recorded for scoring purposes.
The NART is widely used as an estimate of premorbid
ability given the premise that reading ability is relatively
independent of brain damage. Furthermore, NART
performance appears to be impervious to the effects of
many neurological and psychiatric conditions [64]. In a
retrospective validity study of the NART, there was a
strong correlation (r = 0.73; P < 0.001) between
Intelligence Quotient (IQ) age 11 and NART
performance at age 77 [64]. The NART will be used
to characterise the HF sample and match the healthy
non-HF controls on premorbid intelligence.
Baseline and follow-up measures to be collected from carers
Carers will be asked to complete seven brief questionnaires:
I. A health screening questionnaire will be used to
identify the presence of specific health problems
(cardiac, metabolic, diabetic, respiratory, muscular,
family history, treatment precautions, and physical
activity) and will be used for descriptive purposes.
II. Carer contribution to HF self-care (CC-SCHFI) [65]
is derived from the SCHFI and assesses the career’s
contribution to self-care maintenance and
management behaviours. This information will be
used to provide a more comprehensive assessment
of the patient participant’s engagement in self-care.
III. Control Attitudes Scale - Revised (CAS-R) [41] will
be administered to measure the carer’s perceived
control in relation HF management. Each item is
measured on a 5-point Likert scale ranging from 1
(strongly disagree) to 5 (strongly agree) and has been
shown to have good internal reliability in a HF
population (α = 0.76) [41]. This scale has been
adapted for administration to the caregivers of
patients with cardiac disorders [42,43].
IV. Carers will also identify how their relationship with
the HF patient functions in terms of managing HF
symptoms using the dyadic HF care typology
(described above).
V. SF-12 will be administered (described above) as an
indication of the quality of life of the carer.
VI. Modified Caregiver Strain Index (MCSI) assesses
the causes, and the degree of strain, and changes in
strain over time. It has four domains of strain:
financial, physical, psychological and social and
personal. The reported internal reliability of the
MCSI is high (Cronbach’s α = 0.90) and it correlateswith care recipient’s functioning [66,67]. The tool
will be administered to monitor changes in carer
strain from baseline to 3- and 12-month follow-up.
VII.To measure of HF patients’ level of functioning,
carers will be asked to indicate the HF participants’
level of independence in daily activities using the
validated Instrumental Activities of Daily Living
(IADL) Scale [68]. This instrument assesses how
much help the individual requires to perform each
of eight tasks (using the telephone, shopping, food
preparation, housekeeping, laundry, transportation,
managing medications and home finances). A score
of 1 indicates ‘no help’, and higher scores indicate
increased dependence. Performing instrumental
daily activities successfully requires a high level of
skill and judgment: therefore, greater dependency is
likely to be sensitive to mild changes in cognitive
capacity [69].Measures to be collected from healthy control group
The healthy control group will be matched to the HF
patient group on age, premorbid intelligence and gender,
and will undergo neuropsychological assessment as
described above and highlighted with asterisks in Table 1.
Psychosocial demographics, including social support and
anxiety and depression, will also be collected to allow
comparisons of the healthy controls and HF participants.Additional patient outcome measures
There will be 3 additional outcome measures of self-
care collected at Assessments One (2 to 4 weeks post
cognitive training) and Two (12 months post cognitive
training):
The first is patient engagement in self-care. On
enrolment into the study, HF patients will be provided
with a symptom monitoring diary by the research
assistant who will explain how to use them. At Assess-
ments One and Two the research assistant will review
whether the diaries have been completed. The
research assistant will also collect practical data on
how the HF patient performs daily weighing, monitors
their fluid intake; reads food labels to determine the
sodium content of food; and follows their prescribed
medication regimen.
The research assistant will ask the HF nurse caring for
the patient participant to complete a questionnaire to
assess the nurses’ perception of the patient’s engagement
in HF self-care.
The Unplanned Healthcare Utilisation Questionaire
will be used to collect information about unscheduled
visits to GP, cardiologist, HF nurse and emergency
department. Information about survival will be collected
from hospital records.
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Primary study outcomes are patient engagement in HF
self-care behaviours from both self-report (SCHFI) and
the objective assessments from the carer, researcher and
nurse, described above. Secondary outcomes are those
not directly related to HF self-care behaviors but rele-
vant to HF: quality of life; BNP, ‘Up and Go’ test, hospital
readmissions, survival and transfer effects. To examine
near to far transfer effects of the cognitive training we
shall use PM tests aligned (or similar) to the training
task, MIST and Virtual Week for near transfer effect. To
examine for far transfer effects we will reassess overall
cognitive function at Assessments One and Two. The
TIADL and naturalistic PM task will assess transfer to
everyday functioning, and will potentially represent
somewhere between near and far transfer.
Interventions
Included in this study are 2 interventions: 1) PM training
intervention (Virtual Week Training Program) and 2)
the active control intervention (non-adaptively difficult
word puzzles). The active control intervention is active
in the sense that participants undergo an intervention
that they may perceive as a plausible technique for
improving cognition, but which is not evidenced to do
so, similar to a placebo control. Relative to a passive
control, such as usual care in a medical context, an active
control is a more rigorous test of the effects of cognitive
training.
PM training intervention - Virtual Week Training Program
HF patients randomly allocated to receive the computer-
based PM training strategy (Virtual Week Training
Program) will continue to receive their usual care from
service providers; this may be from any combination of
nurse-led chronic disease management, specialised HF
outpatient clinics, or outpatient rehabilitation programs.
As a supplement to usual care, the Virtual Week Training
Program intervention will have all the critical features of a
restorative training task with lots of repetition and
adaptive difficulty whereby the task starts at a relatively
easy level and then progressively becomes more difficult,
adapting to the performance level achieved by the partici-
pant. A key feature of this program is the distributed
practice of the cognitive training, in this case over 6 weeks,
rather than massed practice in 1 or 2 long sessions.
Another training feature is that the Virtual Week Training
Program provides feedback at the conclusion of each
‘virtual day’ (which will occur twice per session), so that
participants are aware of their performance on each day
and of their progression through the difficulty levels.
Previous training tasks have mixed success with often low
levels of far transfer, and this is arguably because the
training tasks have not been specifically targeted towardsdesirable outcome behaviours. We have developed
‘virtual days’ that mimic many of the daily tasks HF
patients would be expected to follow in real life. For
example, when patients participate in the Virtual Week
Training Program, they are asked to simulate activities
like weighing themselves daily in the morning, evaluating
their HF symptoms in the evening, and assessing their
fluid intake at several times during the day. In addition,
there are event-based tasks that involve exercise.
Therefore, the Virtual Week Training Program is more
related to PM than many previous restorative training
programs that train performance on basic cognitive
tasks, such as working memory [33].
The Virtual Week Training Program has been sub-
stantially developed since the reported pilot [33]. The
number of ‘virtual days’ has been doubled and each of
the 48 days contains a different set of event cards to
simulate unique sets of daily activities and PM tasks.
This avoids the repetition of ‘virtual days’ that was
needed in the pilot and extends the sessions from 12
sessions over 4 weeks to 24 sessions over 6 weeks. The
training program is now fully automated so that partici-
pants can complete the training sessions in their own
homes without needing to travel to the laboratory for
supervised administration.
The research assistant conducting the training sessions
will be blinded to baseline assessments. It is anticipated
that the first training session will take 40 to 45 minutes
where the patient will be provided with a USB version of
the Virtual Week Training Program to use on their home
computer over 6 weeks. Patients will be instructed to use
the training program 4 times per week over 6 weeks.
Each training session will take approximately 20 to 30 -
minutes to complete. On insertion of the flash drive into
the patient’s computer, prompts will initiate the training
at the appropriate level and limit the number of ‘virtual
days’ (2) that can be completed in 1 session and the
number of sessions that can be completed on each actual
day (1) and each actual week (4). The Virtual Week
Training Program records all responses, scores multiple
measures of performance, and uploads the data to the
experimenter’s database at the completion of each
session so that the patient’s progress can be monitored.
Face-to-face support will be arranged where needed.
Active control group - puzzle training
To determine whether cognitive training has any additional
health benefits for HF patients there will be an active
control group to enable comparisons of outcome measures
between the two HF groups. HF patients randomly
allocated to the active control will continue to receive their
usual care from service providers; this may be from any
combination of nurse-led chronic disease management, spe-
cialised HF outpatient clinics, or outpatient rehabilitation
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completing computerised word puzzles, and will be
presented not as a control activity but as a plausible
training activity. This particular control has been
implemented due to the widespread belief that ‘brain
teasers’ (for example, crossword puzzles) help with
brain fitness, yet evidence for the efficacy of commercial
brain-training exercises is limited [70].
To control for the social and participatory features of
the PM training, patient participants in the control
group will be asked to complete a set of word puzzles
for a similar amount of time to the restorative memory
training condition. That is, they will be asked to spend
20 to 30 minutes per day completing a set of word
puzzles, 4 times per week, over 6 weeks. The key
distinguishing features of the word puzzles compared
to the Virtual Week Training Program is that the
puzzle difficulty is manageable and non-adaptive.
Compared to the PM training group, patient partici-
pants in the control group will have similar levels of
contact with the research assistant: the introductory
sessions will be conducted face-to-face to introduce
them to the puzzle training; subsequent telephone
contact twice a week to support and monitor their
participation in the puzzle training. Patient partici-
pants will be given specific instructions and support to
Email screenshots to the research assistant to monitor
their participation and progress.
Randomisation and allocation concealment
Using CONSORT principles [71] HF patients will be
randomised to 1 of the 2 study interventions: 1) usual
care plus PM training (see Figure 1) or 2) active control
group. Block randomisation will be allocated via a
computer generated number prepared by an investigator
with no involvement in data collection. Block randomisa-
tion with 1:1 ratio will be used to keep the 2 groups at
similar sizes. Once the HF patient has consented to the
study and baseline measures have been collected the
research assistant will contact one of the training study
investigators, who are independent of the recruitment
process and data collection, for allocation consignment.
Research assistants collecting baseline measures will not
be informed of the patient’s assignment. Instead, the
research assistant conducting the cognitive training will
be notified when a patient has been randomised to this
intervention. Participants enrolled in the study will be
aware of the training activity they have been allocated
and therefore they will not be blinded to the treatment
allocation.
The study has received ethical approval from the St
Vincent’s Hospital, Melbourne (HREC-A 018/14) and
Australian Catholic University (Ethics Register Number:
2014 175 V) Human Research Ethics Committees andwill conform to the principles outlined in the Declaration
of Helsinki and to the Consolidated Standards of Reporting
Trials (CONSORT) guidelines for a randomised con-
trolled study comparing the efficacy of two non-
pharmacological health interventions [72]. The trial is
registered with the Australian New Zealand Clinical
Trials Registry (ANCTR: reference number #366376).
All subjects will provide written informed consent to
participate in the study.Sample size
Based on data from other relevant trials of patient edu-
cation and HF self-care, an eight-point difference in
standardised self-care scores is a clinically important
change [73]. Using the G*power calculator it was esti-
mated that in order to achieve an 80% power at a 0.05
significance, a sample size of 63 per group is required
to detect a small to medium effect of the self-care inter-
vention on hospitalisations [73]. Using analysis of
covariance (ANCOVA) to examine for clinically signifi-
cant differences in standardised self-care maintenance
and management scores between the 2 HF groups, a
total of 100 patients in each group (200 in total) will
have > 90% power (α of 0.05) to detect a medium effect
size (f2 = 0.4) in the primary endpoint. The probable
requirement to undertake non-parametric statistical
analyses (due to non-Gaussian distributed data) has
been factored into study power calculations in addition
to a 20% intervention refusal rate and loss to follow-up.
The sample size for the comparison of baseline cogni-
tive performance (in particular PM) between 60 HF
patients and a healthy age-matched control group has
been based on previous studies [55,74]. As such, the
sample size has the power to detect significant differences
with moderate effect sizes.Statistical analyses
To compare and confirm cognitive deficits, including
PM, between HF patients and a healthy matched con-
trol, group differences in baseline PM and neuro-
psychological tests will be examined using inferential
statistics (t-test and analysis of variance; ANOVA). To
analyse the changes in each measure assessed at each
time point (baseline, Assessment One and Assessment
Two) we will use separate mixed ANOVAs for all
dependent variables. The within-groups variable will be
testing phase (baseline, Assessment One, Assessment
Two) and the between-groups variable will be Training
group (PM training, word puzzles). Multiple regression
analysis will be performed to identify whether physical,
cognitive, emotional and mental functioning variables are
independent predictors of HF self-care and consulting
behaviours, after adjusting for clinical characteristics. For
Figure 1 Consolidated Standards of Reporting Trials (CONSORT) diagram illustrating study procedures. Key: BNP, brain natriuretic peptide; CAS-R,
Control Attitudes Scale - Revised; CC-SCHFI, Caregiver Contribution Self-Care Heart Failure Index; CRA, Caregiver Reaction Assessment; Dyadic HF
Typology, Dyadic Heart Failure Typology; HADS, Hospital Anxiety and Depression Scale; Heart-FaST, Heart Failure Self-care Screening Tool; HF,
heart failure; MIST, Memory for Intentions Screening Test; MCSI, Modified Caregiver Strain Index; MoCA, Montreal Cognitive Assessment; NP-battery
test, Neuropsychological battery test; Proxy IADL, Proxy measure Instrumental Activities of Daily Living; SCHFI, Self-Care Heart Failure Index; TIADL,
Timed Activities of Daily Living.
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refer to partial η-square values.Dissemination
The dissemination plan includes five scientific papers
that will be submitted to high-quality, peer-reviewed
medical, nursing and psychology journals:1. Prospective memory, a missing link in explaining
effective engagement in HF self-care
2. Changes in HF self-care behaviours following a 6-week
cognitive training program using the Virtual Week
Training Program: a randomised controlled study
3. Can a 6-week, computer-based cognitive training
program improve quality of life and reduce hospital
admissions in HF? A randomised controlled study
Cameron et al. Trials  (2015) 16:196 Page 12 of 144. Does prospective memory change in HF patients
following a 6-week cognitive training program using
the Virtual Week Training Program? A randomised
controlled study
5. Do markers of HF severity change with improved
engagement in self-care behaviours? A randomised
controlled study.
Discussion
Cognitive impairment is a significant problem that
adds to the burden of living with HF. With a growing
interest in PM in ageing [14,75-77] and various other
clinical conditions [15,78-81], this study may further
build on this knowledge, increasing not only our un-
derstanding of cognitive impairment in HF but also
possible management strategies. Although there is
encouraging evidence for the impact of cognitive
training in ageing [33,82-88], few studies have investi-
gated cognitive training in HF as a possible solution to
improve health outcomes [89]. This study will be the
first to explore if PM is associated with HF self-care
and whether the Virtual Week Training Program, a
novel computer-based restorative memory training
program, improves functional outcomes relative to
receiving usual care alone. The strength of this study
will be rigorous baseline measurement of cognitive
function and self-care, and expected improvements
through novel and comprehensive insights into the
prediction of HF self-care and trajectories when educa-
tion, support and cognitive training are applied on an
individually tailored basis.
Results from this study may lead to an innovative
treatment by means of cognitive training, to optimise
HF patients’ engagement in self-care abilities, such as
improving adherence to medications, diet and exercise.
Participation in this study will not result in any known
adverse events: however, potential benefits to patients
include improved wellbeing, and enhanced skills in
managing HF symptoms and as such may impact on
hospital readmissions. In this proposed study, patients
will be randomly allocated to receive either the Virtual
Week Training Program or the non-adaptive computer-
based word puzzles. Both groups will be expected to
complete their allocated training program on 4 days of
the week for 6 weeks. A novel feature of the study is
the collection of not only self-reported self-care but
some objective measures from carers and HF nurses,
and objective measures of functional independence
such as TIADL. Self-reports rely heavily on memory
demands which, if diminished, suggest that question-
naires may not be accurate. Furthermore, the compre-
hensive assessment of patient functioning (BNP, ‘Up
and Go’ test, activities of daily living) will enable us to
investigate if small improvements in PM have anincremental impact on physical functioning and quality
of life. In conclusion, we anticipate that cognitive
training will improve health outcomes in HF patients
and reduce associated healthcare costs.
Trial status
This study is actively recruiting and ongoing.
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